Please Wait
Applying Filters...
menu
    • menu
    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Paxlovid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 11,187Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4Paxlovid

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Paxlovid

    Ritonavir, Nirmatrelvir

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Paxlovid

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Pfizer Inc.

    Ritonavir, Nirmatrelvir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 76

    2020 Revenue in Millions : 0

    Growth (%) : New Launch in 2021

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Paxlovid

    Ritonavir, Nirmatrelvir

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Paxlovid

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Pfizer Inc.

    Ritonavir, Nirmatrelvir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2022 Revenue in Millions : 18,933

    2021 Revenue in Millions : 76

    Growth (%) : 24,812

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Paxlovid

    Ritonavir, Nirmatrelvir

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Paxlovid

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Pfizer Inc.

    Ritonavir, Nirmatrelvir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2023 Revenue in Millions : 1,279

    2022 Revenue in Millions : 18,933

    Growth (%) : -93

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Paxlovid

    Ritonavir, Nirmatrelvir

    arrow
    iPHEX India
    Not Confirmed

    Brand Name : Paxlovid

    U.S.A
    arrow
    iPHEX India
    Not Confirmed

    Pfizer Inc.

    Ritonavir, Nirmatrelvir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2024 Revenue in Millions : 5,716

    2023 Revenue in Millions : 1,279

    Growth (%) : 347

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF